National Institute for Health and Welfare
Helsinki, 00271, Finland
NCT Number: NCT03748160
The aim of this study is to test the effectiveness of communicating the concept of herd immunity on actual influenza vaccine uptake using a randomized controlled trial.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Helsinki, 00271, Finland
The investigators run a large-scale randomized controlled trial (RCT) to understand behavioural processes that guide decisions to vaccinate and test alternative strategies to communicate the concept of herd immunity. The experiment varies the text of postal letters send to individuals eligible for free influenza vaccines. The experiment is run in collaboration with the municipal health authorities.
The investigators identify from the Population Register all individuals who are born in year 1953 or before and resided in the participating municipality on October 01, 2018. The investigators will obtain the postal addresses of these individuals using the Population Register and randomly assign individuals to treatment conditions that differ in the wording of the information material and reception of a text message. Importantly, the extract from the Population Register will also include an individual identifier (social security number) that can be used to match the received type of letter (treatment) with the actual vaccination decision recorded in the Care Register for Health Care to objectively evaluate the impact of received information on vaccine uptake. The matching of postal addresses and vaccination data will be conducted using pseudonymized identifiers. The pseudonymization of individual identifiers will be performed separately for both datasets by professional data management and data security staff of the National Institute for Health and Welfare. The investigators conducting the data analysis will be able to access only pseudonymous data without a possibility to directly identify individuals from the data set. The data will be stored according to the data protection legislation and regulations of the National Institute for Health and Welfare during the research project.
The investigators randomly assign individuals to treatment conditions that differ in the wording of the letters. The authority's standard letter serves as the baseline condition (T1). This letter is extended by communicating the concept of herd immunity and appealing to pro-social preferences by highlighting the fact that vaccinations may effectively prevent infections among people who are not able to vaccinate themselves (especially babies) (T2). To summarize, this study includes a control treatment (T0, no letter) and two active treatment arms with the following contents:
T1 (Mailing) - Standard letter T2 (Herd) - Herd immunity letter
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Intervention consists of two different types of postal letters reminding elderly citizens (65 years and above) about influenza vaccines that are available free of charge from the local health centers
Time frame: up to six months (beginning from November 1 / until April 30)
Number of influenza vaccinations in study population
Time frame: up to six months (beginning from November 1 / until April 30)
We run the statistical analysis by municipality to study ATE in areas with low/high historical vaccine uptake
Finnish Institute for Health and Welfare
Other Gov
Herd Immunity Communication and Influenza Vaccine Uptake
Acronym: HIIVU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05514002
Infections, Influenza, Human
Tucson, Arizona, United States
View Trial DetailsNCT04494412
Arthralgia, Infections
Florence, Italy
View Trial DetailsNCT05501561
Infections, Influenza, Human
Tempe, Arizona, United States
View Trial DetailsNCT06087640
Infections, Influenza, Human
Birmingham, Alabama, United States
View Trial Details